Nausea and vomiting (common when starting the medication but usually temporary) Diarrhea or constipation Mild fatigue or dizziness Loss of muscle mass if weight loss is too rapid A study published in JAMA found that GLP-1s significantly reduce body weight and A1C levels (a marker of blood sugar control) in older adults
Ipamorelin adjustments are based on symptoms and lab markers: If sleep and recovery improve at 200 mcg, you may stay at that dose If you want more pronounced GH effects, your physician may increase to 250 to 300 mcg A second daily dose (morning, fasted) can be added for enhanced GH support If water retention or joint stiffness develops, the dose may be reduced Key lab work at the 6 to 8 week mark: IGF-1 (confirms Ipamorelin is producing a GH response) thorough metabolic panel HbA1c and fasting glucose Lipid panel Lab work and monitoring Phase 4: Sustained Progress (Weeks 12 through 24) By this stage, both peptides are dialed in and working together effectively
doi: 10.1186/1550-2783-4-12 23 FinkJSchoenfeldBJHackneyACMatsumotoMMaekawaTNakazatoKet al
Some patients find that injecting in the evening minimizes nausea during waking hours, since side effects often peak 24 hours post-injection
Zepbound has demonstrated impressive results in clinical studies, with patients achieving an average of 15% weight loss over 72 weeks when used in combination with a reduced calorie diet and increased physical activity
If insurance denies coverage or charges prohibitive copays, compounded semaglutide at $199 monthly makes long-term treatment financially feasible